- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/65 - Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Patent holdings for IPC class C07K 14/65
Total number of patents in this class: 318
10-year publication summary
|
26
|
23
|
20
|
25
|
28
|
19
|
25
|
24
|
15
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Silver Creek Pharmaceuticals, Inc. | 29 |
20 |
| Takeda Pharmaceutical Company Limited | 2706 |
16 |
| Amicus Therapeutics, Inc. | 351 |
14 |
| BioMarin Pharmaceutical Inc. | 374 |
14 |
| Novartis AG | 10709 |
11 |
| Biocon Limited | 222 |
10 |
| Versameb AG | 19 |
8 |
| The Brigham and Women's Hospital, Inc. | 2217 |
6 |
| IGF Oncology, LLC | 16 |
6 |
| Upside Foods, Inc. | 127 |
5 |
| Oak Hill Bio Limited | 27 |
5 |
| F. Hoffmann-La Roche AG | 7947 |
4 |
| The Trustees of the University of Pennsylvania | 4354 |
4 |
| Julius-maximilians-universitat Wurzburg | 278 |
4 |
| Universitat Autonoma de Barcelona | 324 |
4 |
| In3bio Ltd. | 23 |
4 |
| Juvena Therapeutics, Inc. | 17 |
4 |
| Hoffmann-La Roche Inc. | 3484 |
3 |
| The Regents of the University of California | 20137 |
3 |
| Amgen Inc. | 4118 |
3 |
| Other owners | 170 |